Mapping the Melatonin Receptor. 4. Comparison of the Binding Affinities of a Series of Substituted Phenylalkyl Amides
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (9) , 1797-1805
- https://doi.org/10.1021/jm9508189
Abstract
A series of 2-, 3-, and 4-substituted phenylalkyl amides were prepared as potential melatonin analogs in order to investigate the nature of the binding site of the melatonin receptor in chicken brain. The length of the alkyl chain was systematically varied from n = 1 to 4, and methoxyl substituents were incorporated into the phenyl ring at the 2-, 3-, and 4-positions. The maximum binding affinity was found to occur when n = 3 and when the methoxyl substituent was in the 3-position, the direct analog of the carbon framework of melatonin in which the 1,2-atoms of the indole ring have been removed. Whereas there was only a relatively small decrease in binding affinity for the corresponding 2-methoxy derivatives, 4-methoxyl substitution led to a large decrease in binding affinity, suggesting that the binding sites for the side chain and methoxyl group could not now be occupied at the same time. As in the indole analogs of melatonin, replacement of the methyl group of the amide by a longer alkyl chain led to an increase in binding affinity for ethyl and propyl with a subsequent decrease in binding affinity for butyl chains. Thus N-propanoyl-3-(3-methoxyphenyl)propanamine (6f) has a binding affinity of 5.6 nM, a remarkably high affinity for so simple a compound. Substitution of halogen for 3-methoxyl in the propanamide series gave a series of compounds with lower, but still substantial, binding affinities, the 3-chloro derivative 7e showing the highest affinity, 113 nM. In the case of the 3-fluoro propanamides, a maximum in the binding affinity was not observed in the series synthesized, and these derivatives will merit further exploration. These results demonstrate the utility of simple, readily modified phenylalkylamines as a “framework” for studying the effect of changes in the nature and position of substituents on the melatonin receptor binding affinity.Keywords
This publication has 17 references indexed in Scilit:
- Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogueEuropean Journal of Pharmacology, 1995
- The Nuclear Receptor for Melatonin Represses 5-Lipoxygenase Gene Expression in Human B LymphocytesJournal of Biological Chemistry, 1995
- Mapping the Melatonin Receptor. 3. Design and Synthesis of Melatonin Agonists and Antagonists Derived from 2-PhenyltryptaminesJournal of Medicinal Chemistry, 1995
- Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligandNucleic Acids Research, 1995
- Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily.Journal of Biological Chemistry, 1994
- Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores.Proceedings of the National Academy of Sciences, 1994
- Melatonin: Binding site characteristics and biochemical and cellular responsesNeurochemistry International, 1994
- Melatonin receptors: Localization, molecular pharmacology and physiological significanceNeurochemistry International, 1994
- Pharmacological identity of 2-[125I]iodomelatonin binding sites in chicken brain and sheep pars tuberalisBrain Research, 1991
- Pharmacology and function of melatonin receptorsThe FASEB Journal, 1988